Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
Noosa News13 hours agoWine truck crashed on Pacific Motorway at Tanah Merah with long delays expected; Telstra warns some Samsung phones may not connect to Triple Zero
-
Noosa News16 hours agoYoung female gymnasts allege bullying before being forced out
-
Business12 hours agoHow the average superannuation could turn into $1 million with just $10 a day
-
Business8 hours agoRegis Healthcare snaps up two Victorian aged care homes in $45m deal